Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues.

Ditkowski B, Veloso TR, Bezulska-Ditkowska M, Lubig A, Jockenhoevel S, Mela P, Jashari R, Gewillig M, Meyns B, Hoylaerts MF, Heying R.

J Vis Exp. 2019 Jan 7;(143). doi: 10.3791/58476.

PMID:
30663688
2.

Clinical Characteristics of Infective Endocarditis in Children.

Kelchtermans J, Grossar L, Eyskens B, Cools B, Roggen M, Boshoff D, Louw J, Frerich S, Veloso TR, Claes J, Ditkowski B, Rega F, Meyns B, Gewillig M, Heying R.

Pediatr Infect Dis J. 2019 May;38(5):453-458. doi: 10.1097/INF.0000000000002212.

PMID:
30346369
3.

Marginal role of von Willebrand factor-binding protein and coagulase in the initiation of endocarditis in rats with catheter-induced aortic vegetations.

Mancini S, Oechslin F, Menzi C, Que YA, Claes J, Heying R, Veloso TR, Vanassche T, Missiakas D, Schneewind O, Moreillon P, Entenza JM.

Virulence. 2018;9(1):1615-1624. doi: 10.1080/21505594.2018.1528845.

4.

Are plasma proteins key players in the pathogenesis of infective endocarditis?

Veloso TR, Ditkowski B, Mela P, Hoylaerts MF, Heying R.

J Thorac Cardiovasc Surg. 2018 Aug;156(2):738-739. doi: 10.1016/j.jtcvs.2018.04.053. No abstract available.

PMID:
30011766
5.

Assessment of the Dual Role of Clumping Factor A in S. Aureus Adhesion to Endothelium in Absence and Presence of Plasma.

Claes J, Ditkowski B, Liesenborghs L, Veloso TR, Entenza JM, Moreillon P, Vanassche T, Verhamme P, Hoylaerts MF, Heying R.

Thromb Haemost. 2018 Jul;118(7):1230-1241. doi: 10.1055/s-0038-1660435. Epub 2018 Jun 17.

PMID:
29909601
6.

Bacterial adherence to graft tissues in static and flow conditions.

Veloso TR, Claes J, Van Kerckhoven S, Ditkowski B, Hurtado-Aguilar LG, Jockenhoevel S, Mela P, Jashari R, Gewillig M, Hoylaerts MF, Meyns B, Heying R.

J Thorac Cardiovasc Surg. 2018 Jan;155(1):325-332.e4. doi: 10.1016/j.jtcvs.2017.06.014. Epub 2017 Jun 16.

PMID:
28712577
7.

Clumping factor A, von Willebrand factor-binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall.

Claes J, Liesenborghs L, Peetermans M, Veloso TR, Missiakas D, Schneewind O, Mancini S, Entenza JM, Hoylaerts MF, Heying R, Verhamme P, Vanassche T.

J Thromb Haemost. 2017 May;15(5):1009-1019. doi: 10.1111/jth.13653. Epub 2017 Mar 23.

8.

Shear-Resistant Binding to von Willebrand Factor Allows Staphylococcus lugdunensis to Adhere to the Cardiac Valves and Initiate Endocarditis.

Liesenborghs L, Peetermans M, Claes J, Veloso TR, Vandenbriele C, Criel M, Lox M, Peetermans WE, Heilbronner S, de Groot PG, Vanassche T, Hoylaerts MF, Verhamme P.

J Infect Dis. 2016 Apr 1;213(7):1148-56. doi: 10.1093/infdis/jiv773. Epub 2016 Jan 6.

PMID:
26743845
9.

Aspirin plus ticlopidine prevented experimental endocarditis due to Enterococcus faecalis and Streptococcus gallolyticus.

Veloso TR, Oechslin F, Que YA, Moreillon P, Entenza JM, Mancini S.

Pathog Dis. 2015 Nov;73(8):ftv060. doi: 10.1093/femspd/ftv060. Epub 2015 Aug 26.

10.

Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.

Veloso TR, Mancini S, Giddey M, Vouillamoz J, Que YA, Moreillon P, Entenza JM.

Vaccine. 2015 Jul 9;33(30):3512-7. doi: 10.1016/j.vaccine.2015.05.060. Epub 2015 Jun 3.

PMID:
26048778
11.

Reply to Eisen and McBryde.

Veloso TR, Que YA, Moreillon P, Entenza JM.

J Infect Dis. 2015 Aug 15;212(4):674-5. doi: 10.1093/infdis/jiv133. Epub 2015 Mar 9. No abstract available.

PMID:
25754979
12.

In vivo effect of flucloxacillin in experimental endocarditis caused by mecC-positive staphylococcus aureus showing temperature-dependent susceptibility in vitro.

Mancini S, Laurent F, Veloso TR, Giddey M, Vouillamoz J, Vandenesch F, Moreillon P, Entenza JM.

Antimicrob Agents Chemother. 2015 Apr;59(4):2435-8. doi: 10.1128/AAC.04733-14. Epub 2015 Jan 20.

13.

Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans?

Veloso TR, Que YA, Chaouch A, Giddey M, Vouillamoz J, Rousson V, Moreillon P, Entenza JM.

J Infect Dis. 2015 Jan 1;211(1):72-9. doi: 10.1093/infdis/jiu426. Epub 2014 Aug 1.

PMID:
25086177
14.

Streptococcus tigurinus is highly virulent in a rat model of experimental endocarditis.

Veloso TR, Zbinden A, Andreoni F, Giddey M, Vouillamoz J, Moreillon P, Zinkernagel AS, Entenza JM.

Int J Med Microbiol. 2013 Dec;303(8):498-504. doi: 10.1016/j.ijmm.2013.06.006. Epub 2013 Jun 20.

PMID:
23856340
15.

Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis.

Veloso TR, Chaouch A, Roger T, Giddey M, Vouillamoz J, Majcherczyk P, Que YA, Rousson V, Moreillon P, Entenza JM.

Infect Immun. 2013 Mar;81(3):697-703. doi: 10.1128/IAI.01030-12. Epub 2012 Dec 17.

16.

Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus.

Pea F, Cojutti P, Petrosillo N, Furlanut M, Entenza JM, Veloso TR, Vouillamoz J, Giddey M, Moreillon P.

Antimicrob Agents Chemother. 2011 Sep;55(9):4496; author reply 4496-7. doi: 10.1128/AAC.00603-11. No abstract available.

17.

In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.

Entenza JM, Veloso TR, Vouillamoz J, Giddey M, Majcherczyk P, Moreillon P.

Antimicrob Agents Chemother. 2011 Sep;55(9):3977-84. doi: 10.1128/AAC.00402-11. Epub 2011 Jul 5.

18.

[Mixed drink consisting of guava (Psidium guajava. L) and forrageira palm (Opuntia fícus-indica): development and acceptability].

Batista RD, Silva RA, Brandão TM, Veloso TR, Neves JA, Santos DN.

Arch Latinoam Nutr. 2010 Sep;60(3):285-90. Spanish.

PMID:
21614825
19.

Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans.

Veloso TR, Amiguet M, Rousson V, Giddey M, Vouillamoz J, Moreillon P, Entenza JM.

Infect Immun. 2011 May;79(5):2006-11. doi: 10.1128/IAI.01208-10. Epub 2011 Feb 14.

20.

Failure of vancomycin continuous infusion against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.

Entenza JM, Veloso TR, Vouillamoz J, Giddey M, Moreillon P.

Antimicrob Agents Chemother. 2011 Jan;55(1):385-7. doi: 10.1128/AAC.00811-10. Epub 2010 Oct 18.

Supplemental Content

Loading ...
Support Center